Do COX-2 inhibitors reduce metachronous cancer development?
Pisegna
Joseph R
JR
Center for Ulcer Research and Education (CURE): VA/UCLA Digestive Diseases Research Center, Building 115, Room 316, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA. joseph.pisegna@va.gov